School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Amneal Pharmaceuticals, Inc. AMRX

Healthcare · Drug Manufacturers - Specialty & Generic

$19.91last close 2026-10-09 · market cap $6.93B · delayed data

Trailing returns

1M+15.42%
3M+16.98%
6M+55.55%
1Y+93.49%
5Y+254.27%

Basis: Adjusted daily closes.

What it does

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE.

Open AMRX in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies